CLYM · Climb Bio, Inc.

NasdaqHealthcareBiotechnology

Climb Bio Inc Is A Clinical-Stage Biotechnology Company Focused On Developing Therapeutics For Patients With Immune-Mediated Diseases. Its Pipeline Includes Budoprutug, An Anti-Cd19 Monoclonal Antibody Being Developed For B-Cell Mediated Diseases Such As Primary Membranous Nephropathy, Immune Thrombocytopenia, And Systemic Lupus Erythematosus, And Clym116, An Anti-April Monoclonal Antibody Being Developed For The Treatment Of Iga Nephropathy.

HealthcareNasdaqUSMid Float

FLOAT

38.3M

FREE FLOAT %

67%

SHARES O/S

57.4M

MARKET CAP

$585.3M

EXCHANGE

Nasdaq

COUNTRY

CLYM Catalyst History

No catalysts recorded for CLYM yet

Day Trader Sniper hasn't classified a publishable catalyst for CLYM yet. New events appear here as they're scored.

Be early on the next CLYM spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

CLYM · Climb Bio, Inc.

CLYM Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.